Doctors Use CRISPR Technology to Boost Cancer Immunotherapy
THURSDAY, Nov. 10, 2022 (HealthDay News) -- Gene editing has for the first time produced modified immune cells finely honed to target and attack cancer cells, researchers say.
THURSDAY, Nov. 10, 2022 (HealthDay News) -- Gene editing has for the first time produced modified immune cells finely honed to target and attack cancer cells, researchers say.